Recommendations on home birth issued by American College of Obstetricians and Gynecologists
The American College of Obstetricians and Gynecologists recently issued a committee opinion stating that although the absolute risk associated with planned home births is low, published medical evidence shows that it is associated with a 2- to 3-fold increase in the risk for newborn death compared with planned hospital births.
The American College of Obstetricians and Gynecologists (ACOG) recently issued a Committee Opinion stating that although the absolute risk associated with planned home births is low, published medical evidence shows that it is associated with a 2- to 3-fold increase in the risk for newborn death compared with planned hospital births.
ACOG maintains that hospitals and birthing centers are the safest places for labor and delivery. Although the College does not support planned home birth, it does support offering those who choose home birth standard components of prenatal care, including screening and treatment for group B streptococci, genetic disorders, and HIV.
The College also recommends that women contemplating home delivery ascertain that they are healthy and at low risk for complications. ACOG also recommends that these women work with a certified nurse midwife, a certified midwife, or a physician who practices in an integrated, regulated health system and who has ready access to consultation and a plan for safe, quick transportation to a nearby hospital in an emergency.
ACOG Committee on Obstetric Practice. Committee opinion No. 476: planned home birth. Obstet Gynecol. 2011;117(2 Pt 1):425-428.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More
